S J McLachlan
Overview
Explore the profile of S J McLachlan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anzai Y, Prince M, Chenevert T, Maki J, Londy F, London M, et al.
J Magn Reson Imaging
. 1997 Jan;
7(1):209-14.
PMID: 9039617
The purpose of the study was to investigate the use of a dextran-coated ultrasmall superparamagnetic iron oxide (USPIO) as a blood pool contrast agent for thoracic and abdominal MR angiography....
2.
McLachlan S, Morris M, LUCAS M, Baum L
Acad Radiol
. 1996 Aug;
3 Suppl 2:S295-6.
PMID: 8796584
No abstract available.
3.
Vassallo P, Matei C, Heston W, McLachlan S, Koutcher J, Castellino R
Invest Radiol
. 1995 Dec;
30(12):706-11.
PMID: 8748183
Rationale And Objectives: To determine if magnetic resonance lymphography performed with subcutaneously administered AMI-227, a nanoparticulate iron oxide contrast agent, can distinguish reactive from tumor-bearing lymph nodes. Materials And Methods:...
4.
Vassallo P, Matei C, Heston W, McLachlan S, Koutcher J, Castellino R
Radiology
. 1994 Nov;
193(2):501-6.
PMID: 7972768
Purpose: To determine the value of magnetic resonance (MR) lymphography enhanced with AMI-227, a superparamagnetic reticuloendothelial-system-specific contrast agent, to distinguish normal and reactive from tumor-bearing lymph nodes. Materials And Methods:...
5.
Lee K, McLachlan S, La Mar G
Biochim Biophys Acta
. 1994 Sep;
1208(1):22-30.
PMID: 8086435
The potential role of hydrogen bonding interactions in modulating the molecular and electronic structure of the active site of solubilized bovine ferricytochrome b5 has been investigated by monitoring solvent isotope...
6.
Anzai Y, Blackwell K, Hirschowitz S, Rogers J, Sato Y, Yuh W, et al.
Radiology
. 1994 Sep;
192(3):709-15.
PMID: 7520182
Purpose: To investigate the efficacy of magnetic resonance (MR) imaging with dextran-coated superparamagnetic iron oxide in the differentiation of metastatic and benign nodes in patients with head and neck cancer....
7.
McLachlan S, Francisco J, Pernicone J, Hasso A
J Magn Reson Imaging
. 1994 May;
4(3):405-11.
PMID: 8061440
A phase III multicenter study was conducted in 89 patients with known intracranial vascular lesions to evaluate an extracellular gadolinium contrast agent, gadoteridol, for intracranial magnetic resonance (MR) angiography. The...
8.
McLachlan S, Morris M, LUCAS M, Fisco R, Eakins M, Fowler D, et al.
J Magn Reson Imaging
. 1994 May;
4(3):301-7.
PMID: 8061425
The safety and magnetic resonance (MR) imaging potential of BMS 180549, a new superparamagnetic iron oxide contrast agent, were evaluated in a phase I, open-label, placebo-controlled study involving 41 healthy...
9.
McLachlan S, Eaton S, De Simone D
Invest Radiol
. 1992 Aug;
27 Suppl 1:S12-5.
PMID: 1506147
Rationale And Objectives: To assess the safety and pharmacokinetics of gadoteridol injection (0.5 M) in 18 healthy male volunteers in a phase I clinical trial. Methods: Volunteers were assigned to...
10.
Litt A, Eidelman E, Pinto R, Riles T, McLachlan S, Schwartzenberg S, et al.
AJNR Am J Neuroradiol
. 1991 Jan;
12(1):149-54.
PMID: 1903574
Fifty patients underwent 2DFT time-of-flight MR angiography and intraarterial contrast angiography for evaluation of possible carotid atherosclerotic disease. The MR angiography technique employed contiguous axial flow-sensitive (short TR/TE) slices that...